Harmony Biosciences Holdings
Stock Forecast, Prediction & Price Target
Harmony Biosciences Holdings (HRMY) stock Price Target by analysts
$45.33
Potential upside: 23.35%
Harmony Biosciences Holdings price prediction
What is Harmony Biosciences Holdings stock analysts` prediction?
Harmony Biosciences Holdings stock forecast: Based on 3 Wall Street analysts` predicted price targets for Harmony Biosciences Holdings in the last 3 months, the avarage price target is $45.33, with a high forecast of $NaN. The average price target represents a 23.35% change from the last price of $36.75.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Harmony Biosciences Holdings stock Price Target by analysts
Full breakdown of analysts given Harmony Biosciences Holdings price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Corinne Jenkins Goldman Sachs | 0% 0/1 | 10 months ago | $28 -23.80% downside | $41.49 | StreetInsider | Previous targets (0) |
Graig Suvannavejh Mizuho Securities | 0% 0/2 | 11 months ago | $52 41.49% upside | $33.6 | TheFly | Previous targets (1) |
Ashwani Verma UBS | 0% 0/1 | 12 months ago | $56 52.38% upside | $36.89 | TheFly | Previous targets (0) |
Graig Suvannavejh Mizuho Securities | 0% 0/2 | about 1 year ago | $42 14.28% upside | $33.55 | StreetInsider | Previous targets (1) |
Francois Brisebois Oppenheimer | 0% 0/1 | about 1 year ago | $56 52.38% upside | $30.39 | StreetInsider | Previous targets (0) |
Ami Fadia Needham | 0% 0/1 | over 1 year ago | $52 41.49% upside | $30.37 | StreetInsider | Previous targets (0) |
Danielle Brill Raymond James | 0% 0/1 | over 1 year ago | $37 0.68% upside | $30.91 | StreetInsider | Previous targets (0) |
Chris Howerton Jefferies | 0% 0/1 | almost 3 years ago | $61 65.98% upside | $47.63 | TheFly | Previous targets (0) |
Harmony Biosciences Holdings Financial Estimates
Harmony Biosciences Holdings Revenue Estimates
Harmony Biosciences Holdings EBITDA Estimates
Harmony Biosciences Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $305.44M N/A | $437.85M 43.35% | $582.02M 32.92% | Avg: $836.81M Low: $820.11M High: $853.32M avg. 43.77% | Avg: $981.35M Low: $961.77M High: $1.00B avg. 17.27% | Avg: $1.21B Low: $1.19B High: $1.23B avg. 23.91% | Avg: $1.79B Low: $1.75B High: $1.82B avg. 47.53% |
Net Income
% change YoY
| $34.59M N/A | $181.46M 424.51% | $128.85M -28.99% | Avg: $236.50M Low: $209.49M High: $254.16M avg. 83.54% | Avg: $302.27M Low: $258.99M High: $362.23M avg. 27.80% | Avg: $438.90M Low: $427.52M High: $450.16M avg. 45.20% | Avg: $779.10M Low: $758.89M High: $799.08M avg. 77.51% |
EBITDA
% change YoY
| $87.54M N/A | $120.35M 37.47% | $221.51M 84.04% | Avg: $7.69M Low: $7.54M High: $7.84M avg. -96.52% | Avg: $9.02M Low: $8.84M High: $9.20M avg. 17.27% | Avg: $11.17M Low: $10.95M High: $11.40M avg. 23.91% | Avg: $16.49M Low: $16.16M High: $16.81M avg. 47.53% |
EPS
% change YoY
| $0.6 N/A | $3.07 411.66% | $2.17 -29.31% | Avg: $3.9 Low: $3.47 High: $4.21 avg. 79.57% | Avg: $5.12 Low: $4.29 High: $6 avg. 31.34% | Avg: $7.27 Low: $7.08 High: $7.46 avg. 42.04% | Avg: $12.91 Low: $12.57 High: $13.24 avg. 77.51% |
Operating Expenses
% change YoY
| $162.39M N/A | $234.18M 44.20% | $268.75M 14.76% | Avg: $2.54B Low: $2.49B High: $2.59B avg. 846.57% | Avg: $2.98B Low: $2.92B High: $3.04B avg. 17.27% | Avg: $3.69B Low: $3.62B High: $3.76B avg. 23.91% | Avg: $5.45B Low: $5.34B High: $5.56B avg. 47.53% |
FAQ
What is Harmony Biosciences Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 58.51% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 209.49M, average is 236.50M and high is 254.16M.
What is Harmony Biosciences Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 33.12% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $820.11M, average is $836.81M and high is $853.32M.
What is Harmony Biosciences Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 57.61% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $3.47, average is $3.9 and high is $4.21.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Harmony Biosciences Holdings stock. The most successful analyst is Corinne Jenkins.